高龄女性卵母细胞积累行PGT-A时玻璃化对囊胚产出与生殖结局的影响
该回顾性观察研究纳入122例平均年龄39.7岁行卵母细胞积累联合PGT-A的高龄女性,每例贡献玻璃化-复苏与新鲜同胞MII卵母细胞队列。玻璃化显著降低每MII囊胚形成率(24.6% vs 44.2%,P<0.0001),但整倍体率、临床妊娠、流产及活产率每单整倍体胚胎移植均无差异,新生儿结局亦无差异。
要点
- 玻璃化显著降低每MII卵母细胞的囊胚形成率,但不影响整倍体率。
- 每单整倍体胚胎移植的临床妊娠、流产及活产率无显著差异。
- 应就囊胚产出减少对胚胎可用性和累积结局的潜在影响进行咨询。
核心结论
- 卵母细胞玻璃化不影响整倍体率或每整倍体胚胎移植的活产机会。
- 高龄患者囊胚产出减少提示应就胚胎可用性和累积结局进行适当咨询。
研究设计与样本
- 回顾性观察研究,纳入122例平均年龄39.7±2.7岁行IVF卵母细胞积累联合PGT-A的女性。
- 每例患者贡献玻璃化-复苏队列和同胞新鲜队列的MII卵母细胞。
- 首次取卵后玻璃化,第二次取卵新鲜卵母细胞同时复苏授精,囊胚期行滋养层活检和NGS-PGT-A。
主要发现
- 玻璃化显著降低每MII分配卵母细胞的囊胚形成率(24.6±34.1% vs 44.2±33.9%,P<0.0001)。
- 每活检囊胚的整倍体率 comparable(38.8% vs 38.0%,P=0.91),非整倍体类型亦 comparable。
- 每单整倍体胚胎移植的临床妊娠率(40.9% vs 61.2%,P=0.11)、流产率(11.1% vs 10.0%,P=0.92)和活产率(36.4% vs 55.1%,P=0.14)无差异。
- 新生儿结局包括胎龄、出生体重和性别分布无差异。
关键数值与推荐
- 主要结局为每MII囊胚形成率,次要结局为整倍体率、妊娠和新生儿结局。
临床怎么用
- 对高龄行卵母细胞积累联合PGT-A的患者,应告知玻璃化可能降低囊胚产出。
- 玻璃化不影响整倍体率及每整倍体胚胎移植的活产率,可继续用于积累策略。
局限性
- 回顾性观察设计,样本量有限(n=122)。
- 妊娠和新生儿结局来自后续冻融胚胎移植,可能受其他因素影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Does oocyte vitrification affect embryological and reproductive outcomes in women of advanced maternal age undergoing oocyte accumulation for PGT-A? DESIGN: Retrospective observational study (n = 122, mean age: 39.7 ± 2.7 years) undergoing IVF with oocyte accumulation for PGT-A. Each patient contributed vitrified‒warmed cohort (VW) and sibling fresh cohort (F) MII oocytes. The first oocyte cohort was vitrified after the first oocyte retrieval and warmed for insemination alongside fresh oocytes from the second oocyte retrieval. Trophectoderm biopsy and next-generation sequencing-based PGT-A were conducted at the blastocyst stage. Primary outcome was blastocyst formation rate per MII; secondary outcomes were euploidy rate, pregnancy and neonatal outcomes, from the proceeding frozen embryo transfer. RESULTS: Vitrification significantly reduced blastulation rate per MII-allocated oocyte (24.6 ± 34.1% VW versus 44.2 ± 33.9% F; P < 0.0001). Despite lower blastocyst yield, euploidy rates per biopsied blastocyst were comparable (38.8% VW versus 38.0% F; P = 0.91) as were the aneuploidy types. Clinical pregnancy (40.9% VW versus 61.2% F, P = 0.11), miscarriage (11.1% VW versus 10.0% F, P = 0.92) and live birth rates (36.4% VW versus 55.1% F, P = 0.14) per single euploid embryo transfer did not differ. No differences were found in neonatal outcomes, including gestational age, birth weight and sex distribution. CONCLUSIONS: Oocyte vitrification does not affect euploidy rates or chance of live birth per euploid embryo transfer. The reduction in blastocyst yield observed in older patients indicates that this population should be appropriately counselled about the potential effect on embryo availability and cumulative outcomes.
引用
- Canosa S, Cimadomo D, Maggiulli R, et al. Oocyte vitrification reduces blastocyst yield but preserves reproductive competence in advanced maternal age patients undergoing oocyte accumulation with PGT-A. Reprod Biomed Online. 2026. PMID: 42119544. doi:10.1016/j.rbmo.2026.105503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。